During this segment, the panelists discuss the increased utilization of magnetic resonance imaging (MRI) scans and its impact in multiple sclerosis (MS).
Moderator Fred Lublin, MD, explains the relationship between MRI scans and radiologically isolated syndrome (RIS).
Although beneficial, Gary M. Owens, MD, explains that even in instances where MRI scans suggest MS, not all patients require treatment.
As explained by Dr Lublin, patient accessibility and affordability is also a challenge. Therefore, the panelists explain how radiology programs manage pre-approval processes for MRI scans.
Dr Owens concludes this segment by explaining that while many plans make it simple for patients with, or suspected of, MS to have access to MRI scans, a “broad net” is a consequence.During this segment, the panelists discuss the increased utilization of magnetic resonance imaging scans and its impact in multiple sclerosis.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More